Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
July 14, 2023 at 11:20 AM EDT
The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by demand for Novo Nordisk's Wegovy and Ozempic.
